Activist investor blasts Alexion's $1.4B Portola buy in scathing open letter | Fierce Pharma
DFWHC and Alexion webinar “Beyond the Pill with Pharma” set for April 14! | DFWHC
Alexion Pharmaceuticals, Inc.
Alexion Pharma Stock Dives On Report It's Under Federal Scrutiny | Investor's Business Daily
Alexion Pharma | Fierce Pharma
Alexion, other drugmakers pay $123M to settle kickback claims - Boston Business Journal
Formation of a blood clot - Xconomy
NICE in U-turn over Alexion's Strensiq
Alexion Pharmaceuticals Inc. moving headquarters to Boston
Alexion Pharmaceuticals - Crunchbase Company Profile & Funding
Alexion Pharmaceuticals - Wikidata
Alexion Pharmaceuticals Global Headquarters, New Haven
Lessons We Can Learn from Alexion's Departure » CBIA
Alexion | Pharmaceutical | Structurally Glazed Curtain Wall | APA Facade
Alexion Pharmaceuticals, Inc. signs to 150,000 s/f lease at Skanska's 121 Seaport : NEREJ
AstraZeneca's Alexion halts ALS trial on lack of efficacy | Reuters
AZ's rare disease Ultomiris snags 3rd FDA nod
Alexion Pharma to pay $8.4 billion for Synageva BioPharma
Articles with Alexion
Alexion Pharma Shares Jump 30% on AstraZenecas $39 Billion Buyout Offer
Alexion finally has a buyer – and it's AstraZeneca with $39bn on the table | Pharmaphorum
Alexion Pharmaceuticals, Inc. (ALXN): Is Big Pharma Crazy for Chasing This Deal? - Insider Monkey
Elliott Management Is Said Push for Changes at Alexion - The New York Times
Alexion to Acquire Wilson Therapeutics | Business Wire
